Related Experiment Video
Updated: May 6, 2026
03:20
Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
Published on: September 22, 2023
2.7K
The Gut-Brain Connection: Exploring the Connection Between the Gastrointestinal System and Parkinson's Disease
Ge YuXuan1, Muhammad Khalid Iqbal2, Bakhtawar Khan2
1Department of Clinical Medicine, College of Basic Medical Science, Dalian Medical University, Dalian, Liaoning Province, China.
CNS & Neurological Disorders Drug Targets
|May 5, 2026
Summary
Parkinson's disease (PD) involves the gut-brain axis, impacting the central nervous system. Research explores gut-brain interactions, potential early symptoms, and novel treatments like probiotics for PD.
Area of Science:
- Neuroscience
- Gastroenterology
- Microbiome Research
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder with motor and non-motor symptoms.
- Emerging evidence implicates the gut-brain axis in PD initiation and progression.
- The central nervous system (CNS) and gastrointestinal (GI) tract interaction is crucial in PD.
Purpose of the Study:
- To review current research on the CNS-GI tract interaction in PD.
- To explore the role of the vagus nerve, enteric nervous system (ENS), inflammation, and microbiome in PD.
- To evaluate PD symptoms, potential early GI indicators, and therapeutic strategies.
Main Methods:
- Comprehensive review of clinical and basic scientific research.
- Analysis of studies on gut bacteria, gut permeability, and alpha-synuclein transport.
- Examination of potential treatments including dietary changes, probiotics, and fecal microbiota transplantation.
Main Results:
- Abnormal gut bacteria distribution, increased gut barrier permeability, and alpha-synuclein transport from gut to brain are observed in PD.
- GI symptoms may serve as early indicators of Parkinson's disease.
- The gut-brain axis plays a significant role in PD pathogenesis.
Conclusions:
- Understanding the CNS-digestive system connection in PD is vital for improved detection and treatment.
- Targeting the gut-brain axis offers new therapeutic opportunities for Parkinson's disease.
- Further research into this complex relationship is warranted for prevention and therapy.
Related Concept Videos
01:22Gut-Brain Axis
249
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
249
01:24Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34
01:05Physiology of Enteric Nervous System and Gut Health
1.6K
The gastrointestinal tract, responsible for the digestion and absorption of nutrients, is safeguarded by the intestinal barrier, which consists of secretory, physical, and immune components. At the forefront is the secretory barrier, composed of essential elements such as mucus, gut microbiota, and defense proteins. They collaborate to break down food particles, facilitate nutrient absorption, and maintain optimal gut health. These secretory components ensure the smooth functioning of the...
1.6K
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:23Irritable Bowel Syndrome
70
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility...
70
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28